USPTO Deadlines
Next Deadline
36 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
September 05, 2025
Extension Available
Until March 05, 2025
Application History
38 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 29, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 28, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jun 27, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jun 4, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Mar 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 4, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Mar 4, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Mar 4, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Mar 4, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Mar 4, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Mar 4, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Mar 4, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Mar 4, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Mar 4, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Mar 3, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Aug 29, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 29, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Aug 29, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Aug 29, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 5, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jan 9, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jan 9, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Dec 20, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Dec 1, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 10, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 9, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 9, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 7, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
Aug 7, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
May 9, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
May 9, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
May 9, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
May 8, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
May 8, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
May 8, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
May 2, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 15, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 31, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, those for use in human oncology; Tyrosine kinase inhibitors for use in the treatment of cancer; Drugs in the nature of pharmaceutical preparations for use in treating chronic myelogenous leukemia
Classification
International Classes
005